跳至主要内容
临床试验/NCT04493554
NCT04493554
已完成
不适用

The Effects of Vasopressin on Attention Control: An Eye-tracking Study

University of Electronic Science and Technology of China1 个研究点 分布在 1 个国家目标入组 89 人2020年7月28日
适应症Healthy
干预措施VasopressinPlacebo
相关药物VasopressinPlacebo

概览

阶段
不适用
干预措施
Vasopressin
疾病 / 适应症
Healthy
发起方
University of Electronic Science and Technology of China
入组人数
89
试验地点
1
主要终点
Effect of vasopressin administration on error rates of saccade/antisaccade for social (facial) versus non-social (shape) stimuli
状态
已完成
最后更新
5年前

概览

简要总结

The main aim of the present study is to investigate whether intranasal vasopressin (20IU) could influence attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.

详细描述

A number of previous studies have reported vasopressin's effect on human social behavior and social cognition, although it remains unclear whether vasopressin could modulate attention allocation including stimulus-driven bottom-up control and goal-directed top-down control. In the current randomized, between-subject, placebo controlled study, 89 healthy male subjects will be recruited and receive either vasopressin (20 IU) or placebo control administered intranasally. 45 minutes after treatment subjects will be required to complete a social-emotional saccade /antisaccade eye-tracking paradigm. The paradigm uses social (happy, sad, angry, fear, and neutral faces) as well as non-social (oval shapes) stimuli to explore social- and emotion-specific effects of vasopressin.

注册库
clinicaltrials.gov
开始日期
2020年7月28日
结束日期
2021年1月1日
最后更新
5年前
研究类型
Interventional
研究设计
Parallel
性别
Male

研究者

发起方
University of Electronic Science and Technology of China
责任方
Principal Investigator
主要研究者

Keith Kendrick

Professor

University of Electronic Science and Technology of China

入排标准

入选标准

  • Healthy participants
  • Non smokers

排除标准

  • Previous or current medical, psychiatric, neurological disorder
  • Regular medication
  • Use of any psychoactive substances in the 24 hours before experiment
  • Contra-indications for vasopressin
  • Contra-indications for eye-tracking data acquisition

研究组 & 干预措施

Vasopressin

Vasopressin (20 IU) intranasally

干预措施: Vasopressin

Placebo

Placebo intranasally

干预措施: Placebo

结局指标

主要结局

Effect of vasopressin administration on error rates of saccade/antisaccade for social (facial) versus non-social (shape) stimuli

时间窗: 45 minutes - 100 minutes after treatment

Comparison between social-specific error rates of saccade/antisaccade between the vasopressin and placebo treatment conditions

Effect of vasopressin administration on saccade/antisaccade latencies towards social (facial) versus non-social (shape) stimuli

时间窗: 45 minutes - 100 minutes after treatment

Comparison between social-specific saccade/antisaccade latencies (in milliseconds) between the vasopressin and placebo treatment conditions

次要结局

  • Emotion-specific effects of vasopressin administration on saccade/antisaccade error rates for the separate facial emotions(45 minutes - 100 minutes after treatment)
  • Emotion-specific effects of vasopressin administration on saccade/antisaccade latencies towards the separate facial emotions(45 minutes - 100 minutes after treatment)

研究点 (1)

Loading locations...

相似试验